English
Jack Castle
Report

Jack Castle

@jackcastle

Corp Strategy & BD @OchreBio 🇺🇲 in 🇬🇧

  • Oxford, England
  • Joined
1.2K Following254 Followers513 Posts
  1. Jack Castle@jackcastle
    Jack Castle
    RT @OchreBio: 💬 Catch @JackCastle, Head of Corporate Development & Business Operations, at @BPatientCap x @CooleyLLP Biotech CEO Event. He'll share insights from Ochre Bio’s deal-making journey. 🕓 4pm – Arrival 🎤 4:15pm – Deal Spotlight interview 🤝 6pm – Networking #TeamOchre
    01089
  2. Jack Castle@jackcastle
    Jack Castle
    RT @OchreBio: MASH affects 1.5-6.45% of the global population. Great to see our name in this @NatureBiotech article, highlighting how some innovative biotechs are helping uncover the molecular mechanisms underpinning this underserved disease ➡️
    0505.9K
  3. Jack Castle@jackcastle
    Jack Castle
    RT @OchreBio: 🚀 Announcing our new multi-year data license agreement with @GSK to investigate the drivers of #liverdisease! Read the announcement ➡️
    07026K
  4. Jack Castle@jackcastle
    Jack Castle
    RT @JackScannell13: Screening and disease models in drug R&D generally identify drug candidates then fail to work in people. So @OchreBio had a cunning plan; use real human livers to model real human livers. @Jack_O_Meara
    Pearl Freier @PearlF
    Boehringer announced a new chronic liver disease partnership w/Oxford, UK-based biotech & @ycombinator alum @OchreBio. $35M upfront & near-term payments & up to $1B if milestones met. CEO is @Jack_O_Meara, CSO @QuinWills, @jackcastle is Head of Corporate Development. Congrats!
    09010.6K
  6. Jack Castle@jackcastle
    Super proud of the Ochre and BI teams coming together for this partnership to break ground in an underexplored area of liver biology. Excited about this one! Thanks to BI for welcoming us.
    Ochre Bio @OchreBio
    🎉 Announcing our partnership with @Boehringer to develop novel regenerative treatments for chronic #liverdisease, which affects affect millions worldwide! Together we will continue to pioneer liver regeneration research. Full announcement➡️
    01241.5K
  7. Jack Castle@jackcastle
    Jack Castle
    RT @OchreBio: 🎉 Announcing our partnership with @Boehringer to develop novel regenerative treatments for chronic #liverdisease, which affects affect millions worldwide! Together we will continue to pioneer liver regeneration research. Full announcement➡️
    08014.9K
  8. Jack Castle@jackcastle
    Jack Castle
    RT @OchreBio: We're featured in the #DecodingBio 2023 Snapshot, highlighting the companies shaping the bio landscape. Our mission is to redefine liver medicines – through an approach rooted in #genomics & human models. Check out the report➡️
    040902
  9. Jack Castle@jackcastle
    Jack Castle
    RT @OchreBio: On the Decoding Life podcast, our Director of In Silico Biology, Dimitris Polychronopoulos shares how advancements in computational #biology are changing the game in #healthcare. Learn more about how Dimitris is 'cracking life's code' ➡️
    020487
  10. Jack Castle@jackcastle
    Jack Castle
    RT @OchreBio: This week, 5-8th June, @Jack_O_Meara & @jackcastle, will be in Boston USA for the BIO International Convention! They're looking forward to meeting industry leaders, and learning about the breakthroughs & challenges facing the #biotech industry today, Connect with us ⬇️
    030610
  11. Jack Castle@jackcastle
    Jack Castle
    RT @OchreBio: We are pleased to announce the appointment of Dr @EliotForster as Chairperson of our Board of Directors 🎉 "We look forward to leveraging his extensive leadership experience towards the development of impactful medicines for #liverdisease patients” ➡️
    0101.4K
  14. Jack Castle@jackcastle
    Jack Castle
    RT @OchreBio: Announcing our $30M Series A! HUGE thanks to our amazing transdisciplinary team for enabling this important moment, as we work towards developing therapies to develop new medicines for chronic liver diseases. 👇 #TeamOchre #biotech #funding #LiverTwitter
    080
  16. Jack Castle@jackcastle
    Jack Castle
    RT @OchreBio: Another coffee chat, and this time with our cell-curious Dr Alice Preston who chats about her experience after switching from academia to industry (and how she likes her coffee of course!). Click below to find out more 👇 #livertwitter #coffeechats #CELL
    010
  18. Jack Castle@jackcastle
    Jack Castle
    RT @OchreBio: Studies found recurrent and de novo NAFLD occurred ~50–70% of all liver transplant recipients in y1 and patients with NASH-related cirrhosis were more likely to die from CVD complications or sepsis post-transplant.
    010
  21. Jack Castle@jackcastle
    Jack Castle
    RT @OchreBio: Have a read below where Rory Cunningham, one of our scientists in New York Lab speaks about liver transplants, the current situation and development of different therapies to help fight against different liver diseases like NASH/NAFLD. #biotech #Liver
    050
  22. Show more posts